Patient Centered Health Management® 1 Pressure from Increases in Cost, Pricing Implications, and Launch Considerations Craig Kephart, President & CEO Centric.

Slides:



Advertisements
Similar presentations
Patient Centered Health Management® What we do Centric provides commercialization, distribution and Health Management services to the Ultra-orphan and.
Advertisements

How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Achieving Affordable and Effective Health Care Reform Karen Ignagni President & CEO April 27, 2009.
Pharmacy Benefit Managers (PBMs)
Patient-/Family Centered Medical Home for Children Why hasn’t it spread further? Chuck Norlin, MD Professor of Pediatrics, University of Utah Adjunct Professor.
Solution in Drug Plan Management 2011 September 8, 2011 Basil Rowe Vice President, Total Rewards and Shared Services Shoppers Drug Mart
Disease State Management The Pharmacist’s Role
Determining Your Program’s Health and Financial Impact Using EPA’s Value Proposition Brenda Doroski, Director Center for Asthma and Schools U.S. Environmental.
A Presentation to the HIE Steering Committee Mendocino Informatics Thursday December 19, 2007 A. John Blair, III, MD CEO, MedAllies.
The EMR Puzzle – Putting the Pieces Together March 10, 2015.
Informatics And The New Healthcare System Information Technology Will Provide the Platform for Quality Improvement in Healthcare for the 21 st Century.
Tracey Moorhead President and CEO May 15, 2015 No Disclosures ©AAHCM.
It’s A Success! Achieving Cost-Effective Disease Management in CHF Sherry Shults, RN BSN CIO South Carolina Heart Center.
Physician Leader Perspective of ACO Transition Scott D. Hayworth, MD, FACOG President and CEO Mount Kisco Medical Group, PC.
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
Capacity Task Force Virginia Health Reform Initiative January 14, 2011
Key Findings : Paying for Self-Management Supports as Part of Integrated Community Health Care Systems July, 2012.
Careers in Pharmaceutical Sales Jim O’Bryan Great Lakes Regional Recruiter Field Sales Division Jim O’Bryan Great Lakes Regional Recruiter Field Sales.
Part 2  In community-based long-term care, the resident may simply need assistance with taking their medications at the right time or with preparing.
Racial/Ethnic Disparities in Health Care: Narrowing the Gap through Solutions Joseph R. Betancourt, M.D., M.P.H. Director, The Disparities Solutions Center.
Midwest Business Group on Health National Employer Survey on Biologics/Specialty Pharmacy August 2011.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
Foundations for a Successful Patient-Centered ACO: First Steps Frank E. Belsito, DO, MMM and James J. Dearing, DO, FAAFP, FACOFP.
1 The Case Management Approach October 11, 2012 International Centre, Mississauga, ON Suzanne Lepage Private Health Plan Strategist.
Recognition of Nursing Excellence. What Is Certification? Certification is defined by the American Board of Nursing Specialties (ABNS) as “the formal.
1 Advancing Recovery: Baltimore Buprenorphine Initiative Tucson Presentation July 29, 2009 Baltimore Substance Abuse Systems.
Navigating the Waters of Health Care Reform and Keeping your Health Care Plan Afloat Jim Williams, Benefit Specialist.
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
Copyright © 2004 by South-Western, a division of Thomson Learning, Inc. All rights reserved. Developed by Cool Pictures and MultiMedia Presentations Copyright.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Practice Management: Tips for a Successful GI Practice James J. Weber, MD President & CEO of Texas Digestive Disease Consultants.
1 Elements Transforming the Delivery System Accountable Health Networks Receive payment for value not volume Drive quality and efficiency by providing.
Methodist Healthcare HCAD 5390.
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
Together.Today.Tomorrow. The BLUES Project Karen C. Fox, PhD Chief Executive Officer.
“RECRUITS: ARE YOU READY TO MAKE CHANGES IN YOUR HOSPITAL?” "I CAN'T HEAR YOU!" Medicaid and Medicare cuts are projected to exceed $123 billion over the.
Integrate Risk Evaluation & Mitigation Strategies (REMS) with Health Management Craig Kephart, President & CEO Centric Health Resources, Inc. July 15,
Meaningful Connections: Patient Centered Medical Home and Health IT David Nace, MD, VP, Chief Medical Officer, McKesson and Company; Chair, Center for.
Managed Care. In the broadest terms, Kongstvedt (1997) describes managed care as a system of healthcare delivery that tries to manage the cost of healthcare,
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
© 2009 The McGraw-Hill Companies, Inc. All rights reserved.
MichPHA Fall Forum A Health System Perspective Rob Casalou, President & CEO, St. Joseph Mercy Hospitals, A Member of Trinity Health.
Population Health Janet Appel, RN, MSN Director of Informatics and Population Health.
Aetna Inc. Smarter is Aetna’s retiree solutions. © 2011 Aetna Inc. XX.XX.XXX.X Month XX, 2011 Presenter Name.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
Pharmacy Benefit Management (PBM) 101
PROPRIETARY & CONFIDENTIAL 1 Specialty Pharmacy Trends and AcariaHealth Specialty Pharmacy Solution AcariaHealth Presentation April 6, 2015.
Concept and Context of CRM
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
Consumer Point-of-Care: What’s New in − 2 − © 2015 ZS Associates | CONFIDENTIAL The 2014 ZS study presented at the POC Summit last year estimated.
0 Employee Benefits Group Health Insurance – Self-Funded.
Population Health: Improving Systems, Practices, and Outcomes SCOTT CONFERENCE CENTER OMAHA, NEBRASKA AUGUST 3, 2016.
Enterprise Imaging The Platform to Value-based Care
Wireless Access SSID: cwag2017
Fostering Workforce Partnerships
Health Advocate Overview
Clinical Pharmacy II.
Changing Specialty Distribution to Clinical Management Models
24-7 Population Health Management Finally… Aligning Patients & Payers
Bending the Cost Curve A Case for Integration.
Specialty Pharmacy Management
Redefining Competition
HR Specialty Products & Services Catalogue Executive Summary
Pharmacy – Fully Insured versus Self Funding
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
The Role of Data and Analytics in the Healthcare Ecosystem
Finance Committee Review
Moving from Health Care to Life Care
Presentation transcript:

Patient Centered Health Management® 1 Pressure from Increases in Cost, Pricing Implications, and Launch Considerations Craig Kephart, President & CEO Centric Health Resources, Inc. May 6, 2009

Patient Centered Health Management® 2 “…the PwC report recommends collaboration with non- drugmakers, particularly on disease management programs. Partnering with other companies on "holistic solutions" rather than "narrow treatments" is a more flexible and "value-enhancing" strategy than, say, mega- merging.” “Drugmakers are going to have to think of themselves more broadly: They can't be makers of drugs. They have to be health gurus, project managers, hospital partners... and so on.” “Outsource R&D…Outsource manufacturing. Outsource sales and marketing, even. Then forge some links with tech companies…and insurers, healthcare providers and benefits managers. Reinvent yourselves, pharma! Don't you know that's the latest trend?” News Source: Fierce Pharma, “Pharma: In 2020, it's not just drugs anymore,” April 30, 2009.

Patient Centered Health Management® 3 “We’re going to see a growth in outcomes guarantees for pharmaceuticals, and it’s very healthy.” - Robert Seidman, formerly Chief Pharmacy Officer for WellPoint. More News

Patient Centered Health Management® 4 Profile of a typical orphan drug Key Differences What Defines Success? Agenda

Patient Centered Health Management® 5 DRUG A Potential Market100,000 Number of Identified Patients5,000 REMSNo Storage Requirements2°C-25C° Route of AdministrationIV Infusion Cost$100,000/year Site of Administration60% home/40% Facility Frequency of AdministrationOngoing Nursing RequiredYes CompetitorsFew or None Value of Reimbursement Expertise High Priority to Managed CareLow Advocacy InfluenceHigh Financial Support NeedsHigh Profile of an Orphan Drug DRUG B 10,000 1,000 Yes None Oral $70,000/year Home Ongoing Side effect mgmt, lab draws None at this time High Low Some High DRUG C 1 1 Yes Possibly Any ? Anywhere Ongoing Possibly Unlikely High Low(?) Some High

Patient Centered Health Management® 6 Have to spread cost of service model and monitoring over fewer patients Focused sales force, specialists, CSLs, etc. need to ensure physician that patient has access to drug and that ongoing care is consistent Fewer patients means every patient is critical for sales – need to build high-touch compliance and loyalty program in order to keep patients on drug Greater demand for outcomes – P4P, value based benefit design. Health management is most effective when fully integrated with distribution Key Differences vs. Larger Drugs

Patient Centered Health Management® 7 Access Compliance Find New Patients MAXIMIZE SALES High-Touch Patient Services Exclusive Distribution REMS/Data LAUNCH DRUG Plan Ahead Build Contingency Plan Integrate with Distribution GET APPROVAL What Defines Success

Patient Centered Health Management® 8 Companies that are willing to put the right structure in place to monitor patients, collect data, and measure outcomes should find that the new regulatory model can work to their advantage. The fewer questions left open, the more thorough the planning and preparation, and the more narrowly defined the REMS plan, the simpler the FDA application process. Execution of this planning process can provide your organization with a competitive advantage over manufacturers who fail to build REMS requirements into their distribution. Get Approval

Patient Centered Health Management® 9 Manufacturer Intake Hub Typical Specialty Model MD/Hospital Patient Payers Wholesaler SP 2SP 3 Patient Assistance SP 1 Patient Typical Specialty Model Buy / Sell

Patient Centered Health Management® 10 Wholesaler Intake Hub Exclusive, Buy Sell MD/Hospital Patient Payers Manufacturer SP 2SP 3 Patient Assistance SP 1 Patient Exclusive Buy / Sell CENTRIC Mfr. Direct Direct MFR. Direct

Patient Centered Health Management® 11 3PL Manufacturer Specialty Pharmacy Hub Services / Reimbursement Nursing Disease / Health Management/REMS Comprehensive Model Centric simplifies distribution Ideal for small patient populations Fewer transactions, lower costs, higher level of service CHR

Patient Centered Health Management® 12 REMS Elements Safe Access Assure Safe Use Mandatory registry Documentation of patient monitoring Nurse training Technology to collect data lab results, patient health measures Assessments and Monitoring Health management Voluntary patient registry Assessments Therapy compliance and adherence Integrated systems with pharmacy dispensing data Enhance Communications Pharmacist education/counseling 24/7 Clinical support Training Nurse training, education, and clinical services

Patient Centered Health Management® 13 Access Compliance Finding New Patients Maximize Sales

Patient Centered Health Management® 14 Health Mgt & PHC (residing at CHR or Pt. Adv) Integrated Health Management & Distribution Manufacturer Payer PhysicianPatient Coordination, claims and reimbursement Rx Pharmacy and clinical services Consented Patient data Fee for service Sell drug, service fees if req’d Aggregated Data & Reporting Data

Patient Centered Health Management® 15 Buyer (Payer) Bargaining Power Characteristic Bargaining Power StrongWeak Product DemandHighLow Switching CostsLow High (not many alternatives) Patient Buyer DemandLowHigh Brand Importance to Patient Buyer LowHigh Products for ultra orphan therapies tend to cause weaker buyer (payer) bargaining power, thereby eliminating barriers to access. Source: Fadia T. Shaya, PhD, MPH, Associate Professor and Director, Center on Drugs and Policy, University of Maryland School of Pharmacy, CBI Strategic Pricing and Modeling Techniques to Demonstrate Product Value, April 6, 2009

Patient Centered Health Management® 16 LOWHIGH Distribution and Patient Outcomes Continuum No Program Multiple Programs, Multiple Providers Multiple SP providers with Integrate Hub Patient Registry, and Health Management Integrated Distribution & Health Management Compliance Adherence Persistency Patient retention Patient satisfaction Self empowerment Clinical outcomes Maximum benefit of therapy

Patient Centered Health Management® 17 Health management tied to distribution allows for interventions at many levels DISTRIBUTION To maximize effectiveness, education must be the right information at the right time and delivered in a customized, personalized way EDUCATION Significant effort is placed into the design of the program prior to launch PROGRAM DESIGN Why the Integrated Plan Works EDUCATION IS NOT THE SAME AS A WELL-INTEGRATED PLAN…

Patient Centered Health Management® 18 Comprehensive Disease Profile 1 Design Process Develop Assessment Dialogue 3 Systems Configuration 4 Outcomes 6 Develop Intervention Goals 2 PHC Deliver Interventions 5 Intervention Goals (Examples) 1. Achieve remission, manage relapses 2. Reduce risk from steroids 3. Decrease ADEs 4. Improve knowledge 5. Reduce relapses 6. Manage stress, depression 7. Improve QOL

Patient Centered Health Management® 19 Education

Patient Centered Health Management® 20 Distribution PHARMACIST NURSE REIMBURSEMENT PHC OPPORTUNITY FOR PATIENT INTERVENTIONS ON MANY LEVELS

Patient Centered Health Management® 21 Peer Health Coach $ Goals Individual Health Plan Quality of Life Compliance Goals Educate Capture Data Impact Outcomes

Patient Centered Health Management® 22 Why the Peer Health Coach Model Works Thus the development of PAGs…They want support, information, education.Patients are driven to interact with other patients.

Patient Centered Health Management® 23 Service Intensity Bonus Service Intensity and Loyal Customers Service intensity is about cost-effectively building relationships with customers. A company can’t offer more service than can be covered by the value of a customer's repeat business. The right level of service intensity is therefore a function of long-term product revenue and cost. Effective service intensity creates loyal customers. You can measure service intensity.

Patient Centered Health Management® 24 Service Intensity Types of Health Care Data There are many different kinds of health care data: Prescription Contact management information Doctor and nurse notes Billing records Electronic medical records Lab data—orders and results Medical and pharmacy claims Survey data—customer satisfaction and assessment data. As long as it can be tied to a customer, it becomes a vehicle for discovery—for learning and improving the customer experience.

Patient Centered Health Management® 25 Service Intensity Infusions from Facility to Home Patients that Centric assists in setting up home infusion services are 1/4 as likely to terminate as all other patients. The process is labor intensive— filled with paperwork and phone calls, but the long-term payoff is loyal customers.

Patient Centered Health Management® 26 Service Intensity Alternative Funding Sources Patients that Centric assists in finding alternative funding sources are also 1/4 as likely to terminate as all other patients. Because almost 1/3 of Centric patients have new or additional payors year to year, inability to pay in one year does not mean the same for future years.

Patient Centered Health Management® 27 Service Intensity Extra Attention to Patient Concerns Patients that Centric assists by finding answers to complicated questions are about 2/5 as likely to terminate as all other patients. The process is labor intensive—but customers appreciate and reward the company’s propensity to give them extra attention.

Patient Centered Health Management® 28 Service Intensity Infusions during Travel Patients that Centric assists in setting up infusion services during travel are 1/10 as likely to terminate as all other patients. By enabling patients to be less held back by their condition, the company becomes an integral part of their lives.

Patient Centered Health Management® 29 Compliance Patient Retention Patient Satisfaction 92.8% 95.8% 95% Time period measured: 2005 – 2007 Source: specialty pharmacy data Integrated Specialty Pharmacy Results Program opt-in rate 98% Over 2,350 patients enrolled in program…

Patient Centered Health Management® 30 Cost Management What are the costs of Distribution? Managing multiple vendors Risk of service breakdowns Inconsistent Service Counterfeiting or diversion REMS requirements Redundancy in data collection efforts Compliance and health management How to mitigate Compress distribution channel Integrate service model with distribution Include distribution and patient services in pricing

Patient Centered Health Management® 31 Pricing & Reimbursement Include Distribution and Patient Services in Pricing Include cost of distribution Include cost of REMS Factor in increased risk Consider impact of ASP Margin pressure from SPs will force more discounts from the manufacturer Discounts drive down ASP Direct distribution can mitigate this impact

Patient Centered Health Management® 32 Does your organization anticipate moving to ASP- based payments in the next months? Yes No My organization has already started to move to ASP-based payments. n = 81 ASP Adoption Source: payer survey, reported August, 2008.

Patient Centered Health Management® 33 Payers are insourcing SP Manufacturers must change how they look at distribution AWP vs. ASP Pricing MFRSPPAYER ASPASP+6% The direct model addresses this issue with a Fee-for-Service approach SPs will look for margin on both fronts but will face challenges... No incentive to SP Margin loss to channel

Patient Centered Health Management® 34 Profile of a typical orphan drug …is changing includes oral medications, subsets of larger patient populations, and personalized medicine Key Differences Require high-touch patient services Higher demand for outcomes data and monitoring What Defines Success? Get Approval Launch Drug Maximize Sales Summary